Showing results (11-20 of 283) with videos related to
Sort By:
Pageof 29
Critical Reviews in Oncology/Hematology|October 18, 2003
Cost analyses of granulocyte colony stimulating factor: a focus on older patients with cancerCharles L BennettBest Practice & Research. Clinical Haematology|March 29, 2005
The blue cross blue shield assessment technology review: summary of findingsCharles L BennettCleveland Clinic Journal of Medicine|November 30, 2011
Pharmacovigilance and PML in the oncology settingCharles L BennettClinical Genitourinary Cancer|July 26, 2023
Hospitalizations Among Veterans Treated for Metastatic Prostate Cancer With Abiraterone or EnzalutamideForest Riekhof, Yan Yan, Charles L Bennett, et al.Cancer Treatment and Research|November 30, 2022
Investigating Severe Adverse Reactions: Examples of the ANTICIPATE Methodology at WorkCharles L Bennett, Shamia HoqueCancer Treatment and Research|November 30, 2022
Moderna, Pfizer-BioNTech, and Johnson & Johnson/Janssen Post-Covid Vaccine Hematological Adverse Events Including Cerebral Venous Sinus Thrombosis (CVST), Thrombotic Thrombocytopenia (VITT), Blood Clots, Increased Vaginal/Menstrual Bleeding and/or Miscarriage, Stillbirth Delivery, or Premature BirthOscar Champigneulle, Charles L BennettCancer Treatment and Research|November 30, 2022
Translating Research into Health Policy: The Citizen Petition Experience with the Food and Drug AdministrationPaul Ray, Charles L BennettProstate Cancer and Prostatic Diseases|September 14, 2022
Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseasesMartin W Schoen, Kenneth R Carson, Seth A Eisen, et al.Oncology (Williston Park, N.Y.)|February 26, 2003
Evaluating the total costs of cancer. The Northwestern University Costs of Cancer ProgramElizabeth A Calhoun, Charles L BennettSeminars in Thrombosis and Hemostasis|November 1, 2012
Thromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR)Whitney D Maxwell, Charles L BennettPageof 29